UPDATE: Ultragenyx Pharma (RARE) Sees Intra-Day Weakness

February 10, 2021 10:38 AM EST

News and research before you hear about it on CNBC and others. Claim your 1-week free trial to StreetInsider Premium here.
(Updated - February 10, 2021 10:43 AM EST)

Ultragenyx Pharma (NASDAQ: RARE) sees mid-day weakness, shares down 1.7%.

UPDATE: Weakness said related to FDA FAERS database showing Dojolvi drug has lead to several recent deaths.



Serious News for Serious Traders! Try StreetInsider.com Premium Free!

You May Also Be Interested In





Related Categories

Trader Talk

Related Entities

FDA